American Society of Hematology

Figure 2.

Cumulative molecular response rates. Cumulative incidence of (A) MMR, (B) MR4, and (C) MR4.5 as per the cohort. In the R/I cohort at baseline, 7 patients were already in MMR, 2 patients were already in MR4, and 1 patient was already in MR4.5; hence, the K-M curves start at 21%, 6%, and 3% from day 0, respectively.

Cumulative molecular response rates. Cumulative incidence of (A) MMR, (B) MR⁴, and (C) MR^4.5 as per the cohort. In the R/I cohort at baseline, 7 patients were already in MMR, 2 patients were already in MR⁴, and 1 patient was already in MR^4.5; hence, the K-M curves start at 21%, 6%, and 3% from day 0, respectively.

This Feature Is Available To Subscribers Only